Filling the need for trusted information on national health issues…

Clinical Research/R&D

  • Your Selections:

Refine Results

date

Tags

Starting ART Early May Reduce Risk Of Developing More Serious HIV-Related Infections, WHO-Supported Studies Confirm

WHO: WHO confirms antiretroviral therapy reduces the risk of life-threatening HIV-related infections “Adults and children with HIV who start antiretroviral therapy (ART) as early as possible reduce their risk of developing serious HIV-related infections, according to new findings published in the journal Clinical Infectious Diseases on 15 June 2016…” (6/20).

Developing-Country-Based Research Presents Opportunity For Cost-Effective Health Innovations

Project Syndicate: Health Care Innovation in the Global South Shams El Arifeen, epidemiologist, senior scientist, and senior director of the Maternal and Child Health Division at icddr,b “… [I]nnovators living and working in resource-poor settings are among the best equipped to develop and test cost-effective health solutions. After all, nobody…

Federal Officials Outline Steps To Address Antimicrobial Resistance At Congressional Hearing

CIDRAP News: Feds detail range of steps to limit antibiotic resistance “Federal officials at a congressional hearing this week outlined a range of measures to combat antimicrobial resistance (AR), such as increased laboratory capacity, a national genome sequencing database, and an incubator program to help get new experimental drugs into…

Gene-Altered Mosquitoes Likely To Be Used As Disease Prevention Method, Bill Gates Says

Bloomberg News: Gates Says Altered Mosquito Is Next Weapon to Fight Malaria “Bring on the genetically modified mosquitoes, Bill Gates says. In recent years, biologists armed with a new gene-editing technology have proposed altering mosquitoes so they’re more resistant to diseases like malaria and dengue. Using a mechanism known as…

In CGD Podcast, Jim O’Neill Discusses Ways To Address Antibiotic Resistance

Center for Global Development’s “CGD Podcast”: ‘Google For Doctors’: How the G20 and World Bank Can Help Tackle Antibiotic Resistance — Podcast with Lord Jim O’Neill Rajesh Mirchandani, vice president of communications and policy outreach at CGD, speaks with Lord Jim O’Neill, a minister in the U.K. Treasury, about the…

U.S. House Committee Hears Testimony Regarding Genetically Modified Mosquitoes

CQ Magazine: A British Firm’s Zika Solution Catches Congress’ Eye “Hadyn Parry, chief executive of the British biotech company Oxitec, made a case to the House Science, Space, and Technology Committee last month that his firm can help halt the spread of the Zika virus, if only the Food and…

U.S., Cuba To Collaborate On Public Health Issues, Including Global Health Security, R&D

CNBC: U.S. announces health collaboration with Cuba; will coordinate on diseases, R&D “The United States said Monday it will collaborate with Cuba on health issues, the latest step in an historic rapprochement between the one-time bitter adversaries. An agreement between the U.S. and Cuba calls for ‘coordination across a broad…

Blog Post Describes Experimental Toxic Shock Syndrome Vaccine Research

Bill & Melinda Gates Foundation’s “Impatient Optimists”: Vaccine against Toxic Shock Syndrome successfully tested in a Phase I trial Melvin Sanicas, global health fellow and program officer with the Gates Foundation, discusses toxic shock syndrome (TSS) and research into an experimental vaccine (6/13).

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.